{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:41:49Z","timestamp":1790649709563,"version":"4.1.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,2,9]],"date-time":"2014-02-09T00:00:00Z","timestamp":1391904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10067-013-2481-2","type":"journal-article","created":{"date-parts":[[2014,2,7]],"date-time":"2014-02-07T23:51:33Z","timestamp":1391817093000},"page":"1311-1316","source":"Crossref","is-referenced-by-count":37,"title":["Renal involvement in secondary amyloidosis of Muckle-Wells syndrome: marked improvement of renal function and reduction of proteinuria after therapy with human anti-interleukin-1\u03b2 monoclonal antibody canakinumab"],"prefix":"10.1007","volume":"34","author":[{"given":"Roberto","family":"Scarpioni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donato","family":"Rigante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Albertazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Melfa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Lazzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,9]]},"reference":[{"key":"2481_CR1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3109\/07853890.2011.598546","volume":"44","author":"L Cantarini","year":"2012","unstructured":"Cantarini L, Rigante D, Brizi MG, Lucherini OM, Sebastiani GD, Vitale A, Gianneramo V, Galeazzi M (2012) Clinical and biochemical landmarks in systemic autoinflammatory diseases. Ann Med 44:664\u2013673","journal-title":"Ann Med"},{"key":"2481_CR2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","volume":"29","author":"HM Hoffman","year":"2001","unstructured":"Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD (2001) Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 29:301\u2013305","journal-title":"Nat Genet"},{"key":"2481_CR3","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/art.10509","volume":"46","author":"E Aganna","year":"2002","unstructured":"Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR, Lachmann HJ, Bybee A, Gaudet R, Woo P, Feighery C, Cotter FE, Thome M, Hitman GA, Tschopp J, McDermott MF (2002) Association of mutations in the NALP3\/CIAS1\/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 46:2445\u20132452","journal-title":"Arthritis Rheum"},{"key":"2481_CR4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.autrev.2011.10.008","volume":"11","author":"D Rigante","year":"2012","unstructured":"Rigante D (2012) The fresco of autoinflammatory diseases from the pediatric perspective. Autoimmun Rev 11:348\u2013356","journal-title":"Autoimmun Rev"},{"key":"2481_CR5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1177\/039463201102400402","volume":"24","author":"L Cantarini","year":"2011","unstructured":"Cantarini L, Lucherini OM, Frediani B, Brizi MG, Bartolomei B, Cimaz R, Galeazzi M, Rigante D (2011) Bridging the gap between the clinician and the patient with cryopyrin-associated periodic syndromes. Int J Immunopathol Pharmacol 24:827\u2013836","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2481_CR6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10238-005-0071-6","volume":"5","author":"JC Hilst van der","year":"2005","unstructured":"van der Hilst JC, Drenth JPH, Simon A (2005) Hereditary periodic fever and reactive amyloidosis. Clin Exp Med 5:87\u201398","journal-title":"Clin Exp Med"},{"key":"2481_CR7","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1002\/art.27696","volume":"62","author":"JB K\u00fcmmerle-Deschner","year":"2010","unstructured":"K\u00fcmmerle-Deschner JB, Tyrrell PN, Reess F, K\u00f6tter I, Lohse P, Girschick H, Huemer C, Horneff G, Haas JP, Koitschev A, Deuter C, Benseler SM (2010) Risk factors for severe Muckle-Wells syndrome. Arthritis Rheum 62:3783\u20133791","journal-title":"Arthritis Rheum"},{"key":"2481_CR8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/kisup.2012.77","volume":"3","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2013","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:5\u201314","journal-title":"Kidney Int Suppl"},{"key":"2481_CR9","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","volume":"356","author":"HJ Lachmann","year":"2007","unstructured":"Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN (2007) Natural history and outcome in systemic AA amyloidosis. N Engl J Med 356:2361\u20132371","journal-title":"N Engl J Med"},{"key":"2481_CR10","doi-asserted-by":"crossref","first-page":"e000364","DOI":"10.1161\/JAHA.111.000364","volume":"1","author":"SM Banypersad","year":"2012","unstructured":"Banypersad SM, Moon JC, Whelan C, Hawkins PN, Wechalekar AD (2012) Updates in cardiac amyloidosis: a review. J Am Heart Assoc 1:e000364","journal-title":"J Am Heart Assoc"},{"key":"2481_CR11","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.20082481","volume":"206","author":"HJ Lachmann","year":"2009","unstructured":"Lachmann HJ, Lowe P, Felix SD, Rordorf C, Leslie K, Madhoo S, Wittkowski H, Bek S, Hartmann N, Bosset S, Hawkins PN, Jung T (2009) In vivo regulation of interleukin 1\u03b2 in patients with cryopyrin associated periodic syndromes. J Exp Med 206:1029\u20131036","journal-title":"J Exp Med"},{"key":"2481_CR12","first-page":"121","volume":"62","author":"BP Hazenberg","year":"2004","unstructured":"Hazenberg BP, van Gameren II, Bijzet J, Jager PL, van Rijswijk MH (2004) Diagnostic and therapeutic approach of systemic amyloidosis. Neth J Med 62:121\u2013128","journal-title":"Neth J Med"},{"key":"2481_CR13","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3109\/0886022X.2013.790300","volume":"35","author":"R Enr\u00edquez","year":"2013","unstructured":"Enr\u00edquez R, Sirvent AE, Padilla S et al (2013) Nephrotic syndrome and AA amyloidosis revealing adult-onset cryopyrin-associated periodic syndrome. Ren Fail 35:738\u2013741","journal-title":"Ren Fail"},{"key":"2481_CR14","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","volume":"349","author":"G Merlini","year":"2003","unstructured":"Merlini G, Bellotti V (2003) Molecular mechanisms of amyloidosis. N Engl J Med 349:583\u2013596","journal-title":"N Engl J Med"},{"key":"2481_CR15","first-page":"947","volume":"57","author":"X Zhu","year":"2011","unstructured":"Zhu X, Liu F, Liu Y, Liu H, Xu X, Peng Y, Sun L, Yuan S (2011) Analysis of clinical and pathological characteristics of 28 cases with renal amyloidosis. Clin Lab 57:947\u2013952","journal-title":"Clin Lab"},{"key":"2481_CR16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.rdc.2013.02.012","volume":"39","author":"BP Hazenberg","year":"2013","unstructured":"Hazenberg BP (2013) Amyloidosis: a clinical overview. Rheum Dis Clin North Am 39:323\u2013345","journal-title":"Rheum Dis Clin North Am"},{"key":"2481_CR17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0049-0172(05)80006-X","volume":"24","author":"MA Gertz","year":"1994","unstructured":"Gertz MA, Kyle RA (1994) Amyloidosis: prognosis and treatment. Semin Arthritis Rheum 24:124\u2013138","journal-title":"Semin Arthritis Rheum"},{"issue":"9275","key":"2481_CR18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","volume":"358","author":"JD Gillmore","year":"2001","unstructured":"Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN (2001) Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet 358(9275):24\u201329","journal-title":"Lancet"},{"key":"2481_CR19","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000343398","volume":"37","author":"M Yilmaz","year":"2013","unstructured":"Yilmaz M, Unsal A, Sokmen M, Kaptanogullari OH, Alkim C, Kabukcuoglu F, Ozagari A, Bor E (2013) Renal involvement in AA amyloidosis: clinical outcomes and survival. Kidney Blood Press Res 37:33\u201342","journal-title":"Kidney Blood Press Res"},{"key":"2481_CR20","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00398.x","volume":"68","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G (2005) Cholesterol and Recurrent Events (CARE) Trial Investigators. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68:237\u20132345","journal-title":"Kidney Int"},{"key":"2481_CR21","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2010020143","volume":"21","author":"A Vilaysane","year":"2010","unstructured":"Vilaysane A, Chun J, Seamone ME, Wang W, Chin R, Hirota S, Li Y, Clark SA, Tschopp J, Trpkov K, Hemmelgarn BR, Beck PL, Muruve DA (2010) The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol 21:1732\u20131744","journal-title":"J Am Soc Nephrol"},{"key":"2481_CR22","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","volume":"360","author":"HJ Lachmann","year":"2009","unstructured":"Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, Gitton X, Widmer A, Patel N, Hawkins PN, Canakinumab in CAPS Study Group (2009) Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med 360:2416\u20132425","journal-title":"N Engl J Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2481-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-013-2481-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-013-2481-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T09:07:35Z","timestamp":1565168855000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-013-2481-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,9]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["2481"],"URL":"https:\/\/doi.org\/10.1007\/s10067-013-2481-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,9]]}}}